A Real World Study Assessing the Quality of Life and Recurrence in Cervical Dystonia Symptoms in Patients Treated with Botulinum Neurotoxin Type A
Latest Information Update: 23 May 2020
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
Most Recent Events
- 20 May 2020 Results to measure the impact of CD symptoms and the reappearance of symptoms with waning BoNT-A effects on patients employment, presented at the 25th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 15 May 2020 New trial record
- 01 May 2020 Results presented at the 72nd Annual Meeting of the American Academy of Neurology